Teva Pharmaceutical Industries Limited TEVA

TEVA Company Overview

Teva Pharmaceutical Industries Limited is a global pharmaceutical company primarily focused on the development, manufacturing, and commercialization of generic medicines, with a complementary portfolio of specialty pharmaceuticals. The company operates within the global pharmaceutical industry, serving healthcare systems, pharmacies, hospitals, and distributors. Teva’s core revenue drivers are its Generic Medicines business, which spans a broad range of therapeutic areas, and its Specialty Medicines portfolio, led by branded treatments for central nervous system and respiratory disorders. Its scale, vertically integrated manufacturing network, and extensive product portfolio position it as one of the world’s largest generic drug manufacturers.

Founded in 1901 in Jerusalem, Teva began as a small wholesale drug business and gradually evolved into a global pharmaceutical manufacturer through decades of organic growth and acquisitions. A pivotal transformation occurred in the late 20th and early 21st centuries as Teva expanded aggressively into international generic markets, including North America and Europe. The acquisition of Actavis Generics in 2016 significantly expanded its global footprint but also increased leverage, shaping subsequent strategic priorities around debt reduction, operational efficiency, and a renewed focus on core products.